Using PET to elucidate novel glucose metabolism in cancer

For decades, FDG (18F-fluorodeoxyglucose) imaging has been a standard clinical method for diagnosing and monitoring cancer. But new research harnessing the technique has challenged what we know about how it – and cancer cells – work. Read more.

Tags: Cancer PET Research

About NMC  |  Products  |  Quote  |  News  |  Resources  |  Contact  |  Sitemap